ArticleESC heart failure2017

Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project.

Antonio Pose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.